Preoperative Staging and Diagnostic Imaging for Colorectal Cancer

Jump To Section

• Importance of Preoperative Staging
• Staging Colon Cancer
• Staging Rectal Cancer
• Diagnostic Imaging Modalities
• Neoadjuvant Therapy Decisions
• Full Transcript

Importance of Preoperative Staging

Preoperative staging is a critical first step in managing colorectal cancer. Dr. Nelya Melnitchouk, MD, emphasizes its universal importance for determining the best treatment pathway for a patient. The primary goal is to rule out metastatic disease, ensuring the cancer has not spread to distant organs like the liver or lungs.

This initial assessment directly informs whether a patient can proceed directly to surgery or requires systemic treatment first. Accurate staging provides a roadmap for oncologists and surgeons to personalize care.

Staging Colon Cancer

Staging colon cancer focuses heavily on identifying distant metastases. Dr. Nelya Melnitchouk, MD, explains that the standard approach involves a CT scan of the chest, abdomen, and pelvis, often called a "metastatic survey." This comprehensive imaging is the best method for initial staging.

If suspicious lesions are found on a CT scan, a liver MRI may be performed for further characterization. Patients with colon cancer typically proceed straight to surgical resection of the primary tumor if no metastases are found.

Staging Rectal Cancer

Staging rectal cancer involves a more detailed assessment of the local tumor environment. Dr. Nelya Melnitchouk, MD, notes that modern diagnostic imaging allows physicians to see the extent of tumor invasion into the rectal wall and check for enlarged, potentially cancerous lymph nodes.

A tumor classified as T3 or T4 is considered locally advanced. The presence of positive lymph nodes also significantly impacts the treatment plan. This detailed local staging is unique to rectal cancer and is crucial for planning neoadjuvant therapy.

Diagnostic Imaging Modalities

Different imaging tools are employed based on the cancer type and location. For rectal cancer, a rectal MRI is very important for evaluating local invasion. Transrectal ultrasound is also a key component of the staging workup.

As Dr. Melnitchouk discussed with Dr. Anton Titov, MD, CT scans remain the cornerstone for initial metastatic surveys in both colon and rectal cancer. In cases of suspected recurrence, a PET-CT scan becomes a useful tool for re-staging and identifying new sites of disease.

Neoadjuvant Therapy Decisions

Preoperative staging directly dictates the use of neoadjuvant therapy. Dr. Nelya Melnitchouk, MD, states that patients with locally advanced rectal cancer (T3/T4 tumors or positive lymph nodes) benefit from neoadjuvant chemoradiation or chemotherapy before surgery.

This approach can shrink the tumor, making it easier to remove and improving outcomes. For colon cancer with confirmed metastases, systemic chemotherapy is often started first. A decision on surgery to remove the primary tumor or metastases is made later based on the patient's response to treatment.

Full Transcript

Dr. Nelya Melnitchouk, MD: Let's start with colon cancer and rectal cancer. There are many therapy options available today for colorectal cancer. How do we choose the right treatment? What are the goals of preoperative staging in colon cancer and rectal cancer?

Preoperative staging is very important in colorectal cancer, as it is with any kind of cancer. It helps determine the best treatment for the patient. You start by ruling out metastatic disease, meaning you want to ensure that colon or rectal cancer has not spread to the liver, lungs, or other organs. You have to exclude metastatic cancer before performing surgery.

The situation is different in rectal cancer. There is more tumor staging that we can do. Diagnostic imaging now allows us to determine the local stage of rectal cancer. We are able to see preoperatively if lymph nodes are enlarged, which could mean they are positive for cancer. We can see the extent of invasion into the rectal wall.

Invasion happens in T3 or T4 stage tumors. Rectal cancer can be locally advanced, with positive lymph nodes. Patients with a T3 or T4 tumor will benefit from neoadjuvant therapy, which could be standard chemotherapy and radiation therapy. But there are also protocols in investigative clinical trials testing experimental preoperative chemotherapy for patients with rectal cancer.

Clinical trials are done more often for patients with rectal cancer and colon cancer. Patients with colorectal cancer often require both MRI and CT imaging. For rectal cancer, rectal MRI is very important, and transrectal ultrasound is also required.

In colon cancer, MRI plays an important role. You may see suspicious lesions on a CT scan, and then you want to make sure those lesions are not metastatic tumors. You would do a liver MRI in colon cancer to rule out metastatic disease.

Of course, when a patient is newly diagnosed with cancer, you also do a metastatic survey. This includes a CT scan of the chest, abdomen, and pelvis. That is the best method to stage colorectal cancer before treatment.

Staging of cancer means determining the extent of cancer. You may be dealing with recurrent colorectal cancer, in which case PET-CT imaging is useful. But initial evaluation of colorectal cancer involves a CT scan of the chest, abdomen, and pelvis.

CT and MRI scans help determine the stage of colon cancer. Diagnostic imaging also helps determine the correct treatment, which might not necessarily be surgical operation first.

You mentioned neoadjuvant chemotherapy treatment. This is cancer treatment before actual surgery happens. In rectal cancer, a patient undergoes preoperative chemotherapy and radiation therapy, or just chemotherapy. In colon cancer, patients usually proceed straight to surgical operation.

Sometimes you do have metastatic disease, though. Often these patients benefit from systemic chemotherapy. Then the decision is made if they are good candidates for surgical treatment. Surgery can involve metastases removal, and surgeons could also remove a primary colon or rectal cancer tumor.